About the Product

Description


Choletype Sachet contains Cholestyramine 4 gm, a bile acid sequestrant used primarily for the management of elevated cholesterol levels and certain conditions associated with excess bile acids. The medicine works within the digestive tract by binding bile acids and facilitating their elimination from the body. This process helps reduce cholesterol levels and supports lipid management when used alongside dietary modifications and lifestyle measures recommended by healthcare professionals.

Cholestyramine helps lower low-density lipoprotein (LDL) cholesterol by preventing the reabsorption of bile acids in the intestine. To compensate for this loss, the liver utilizes cholesterol to produce additional bile acids, thereby reducing circulating cholesterol levels in the blood. In addition to its lipid-lowering properties, the formulation may also be used in specific bile acid-related disorders where binding excess bile acids can help improve patient comfort and gastrointestinal health.

The sachet is commonly prescribed for the management of hypercholesterolemia, dyslipidemia, and certain bile acid-associated conditions under medical supervision. It may be recommended as part of a comprehensive treatment plan that includes dietary control, exercise, and regular monitoring of lipid levels. Its established clinical use and recognized efficacy make it an important therapeutic option in lipid management and related gastrointestinal conditions.

With the growing prevalence of cardiovascular disorders and increasing awareness regarding cholesterol management, Choletype Sachet maintains consistent demand in the cardiology and metabolic care segment. Its established therapeutic role, physician acceptance, and relevance in long-term lipid control contribute to strong market potential. The product offers valuable business opportunities and sustainable growth prospects for retailers and distributors operating within the cardiovascular pharmaceutical sector.

Choletype Sachet may cause constipation, abdominal discomfort, bloating, nausea, flatulence, indigestion, or stomach fullness. Prolonged use may affect the absorption of certain vitamins and medications. Patients should consult their healthcare professional if symptoms persist or worsen.

Choletype Sachet is indicated for hypercholesterolemia, dyslipidemia, elevated LDL cholesterol levels, bile acid-related disorders, and other conditions as determined by a healthcare professional. It helps support cholesterol management and overall cardiovascular health.

This medication should be used under the supervision of a qualified healthcare professional. Adequate fluid intake is recommended during treatment to reduce the risk of constipation. Patients taking other medications should follow appropriate timing recommendations to avoid potential interactions. Regular monitoring of lipid levels and adherence to dietary advice are important for achieving optimal therapeutic outcomes.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the sachets in their original packaging and out of reach of children. Do not use after the expiry date or if the packaging is damaged or compromised.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions